193 related articles for article (PubMed ID: 19729047)
21. Molecular pathogenesis of primary hyperparathyroidism.
Arnold A; Shattuck TM; Mallya SM; Krebs LJ; Costa J; Gallagher J; Wild Y; Saucier K
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N30-6. PubMed ID: 12412775
[TBL] [Abstract][Full Text] [Related]
22. Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4).
Thakker RV
Mol Cell Endocrinol; 2014 Apr; 386(1-2):2-15. PubMed ID: 23933118
[TBL] [Abstract][Full Text] [Related]
23. The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression.
Chen YX; Yan J; Keeshan K; Tubbs AT; Wang H; Silva A; Brown EJ; Hess JL; Pear WS; Hua X
Proc Natl Acad Sci U S A; 2006 Jan; 103(4):1018-23. PubMed ID: 16415155
[TBL] [Abstract][Full Text] [Related]
24. Blocking vascular endothelial growth factor-A inhibits the growth of pituitary adenomas and lowers serum prolactin level in a mouse model of multiple endocrine neoplasia type 1.
Korsisaari N; Ross J; Wu X; Kowanetz M; Pal N; Hall L; Eastham-Anderson J; Forrest WF; Van Bruggen N; Peale FV; Ferrara N
Clin Cancer Res; 2008 Jan; 14(1):249-58. PubMed ID: 18172277
[TBL] [Abstract][Full Text] [Related]
25. Dynamic epigenetic regulation by menin during pancreatic islet tumor formation.
Lin W; Watanabe H; Peng S; Francis JM; Kaplan N; Pedamallu CS; Ramachandran A; Agoston A; Bass AJ; Meyerson M
Mol Cancer Res; 2015 Apr; 13(4):689-98. PubMed ID: 25537453
[TBL] [Abstract][Full Text] [Related]
26. Tissue selectivity in multiple endocrine neoplasia type 1-associated tumorigenesis.
Gracanin A; Dreijerink KM; van der Luijt RB; Lips CJ; Höppener JW
Cancer Res; 2009 Aug; 69(16):6371-4. PubMed ID: 19654304
[TBL] [Abstract][Full Text] [Related]
27. Menin mediates epigenetic regulation via histone H3 lysine 9 methylation.
Yang YJ; Song TY; Park J; Lee J; Lim J; Jang H; Kim YN; Yang JH; Song Y; Choi A; Lee HY; Jo CH; Han JW; Kim ST; Youn HD; Cho EJ
Cell Death Dis; 2013 Apr; 4(4):e583. PubMed ID: 23579270
[TBL] [Abstract][Full Text] [Related]
28. Menin epigenetically represses Hedgehog signaling in MEN1 tumor syndrome.
Gurung B; Feng Z; Iwamoto DV; Thiel A; Jin G; Fan CM; Ng JM; Curran T; Hua X
Cancer Res; 2013 Apr; 73(8):2650-8. PubMed ID: 23580576
[TBL] [Abstract][Full Text] [Related]
29. Enhancer-Mediated Oncogenic Function of the Menin Tumor Suppressor in Breast Cancer.
Dreijerink KMA; Groner AC; Vos ESM; Font-Tello A; Gu L; Chi D; Reyes J; Cook J; Lim E; Lin CY; de Laat W; Rao PK; Long HW; Brown M
Cell Rep; 2017 Mar; 18(10):2359-2372. PubMed ID: 28273452
[TBL] [Abstract][Full Text] [Related]
30. Menin and its interacting proteins: elucidation of menin function.
Balogh K; Rácz K; Patócs A; Hunyady L
Trends Endocrinol Metab; 2006 Nov; 17(9):357-64. PubMed ID: 16997566
[TBL] [Abstract][Full Text] [Related]
31. Global expression profiling of murine MEN1-associated tumors reveals a regulatory role for menin in transcription, cell cycle and chromatin remodelling.
Mould AW; Duncan R; Serewko-Auret M; Loffler KA; Biondi C; Gartside M; Kay GF; Hayward NK
Int J Cancer; 2007 Aug; 121(4):776-83. PubMed ID: 17455252
[TBL] [Abstract][Full Text] [Related]
32. Pancreatic beta-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice.
Bertolino P; Tong WM; Herrera PL; Casse H; Zhang CX; Wang ZQ
Cancer Res; 2003 Aug; 63(16):4836-41. PubMed ID: 12941803
[TBL] [Abstract][Full Text] [Related]
33. Twenty years of menin: emerging opportunities for restoration of transcriptional regulation in MEN1.
Dreijerink KMA; Timmers HTM; Brown M
Endocr Relat Cancer; 2017 Oct; 24(10):T135-T145. PubMed ID: 28811299
[TBL] [Abstract][Full Text] [Related]
34. Tumour suppressor menin is essential for development of the pancreatic endocrine cells.
Fontanière S; Duvillié B; Scharfmann R; Carreira C; Wang ZQ; Zhang CX
J Endocrinol; 2008 Nov; 199(2):287-98. PubMed ID: 18772165
[TBL] [Abstract][Full Text] [Related]
35. Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers.
Machens A; Schaaf L; Karges W; Frank-Raue K; Bartsch DK; Rothmund M; Schneyer U; Goretzki P; Raue F; Dralle H
Clin Endocrinol (Oxf); 2007 Oct; 67(4):613-22. PubMed ID: 17590169
[TBL] [Abstract][Full Text] [Related]
36. Analysis of p27(Kip1) expression in insulinomas developed in pancreatic beta-cell specific Men1 mutant mice.
Fontanière S; Casse H; Bertolino P; Zhang CX
Fam Cancer; 2006; 5(1):49-54. PubMed ID: 16528608
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous changes in the calcium-sensing receptor and the vitamin D receptor under the influence of calcium and calcitriol.
Carrillo-López N; Alvarez-Hernández D; González-Suárez I; Román-García P; Valdivielso JM; Fernández-Martín JL; Cannata-Andía JB
Nephrol Dial Transplant; 2008 Nov; 23(11):3479-84. PubMed ID: 18556746
[TBL] [Abstract][Full Text] [Related]
38. The role of tumor suppressor menin in IL-6 regulation in mouse islet tumor cells.
Song TY; Lim J; Kim B; Han JW; Youn HD; Cho EJ
Biochem Biophys Res Commun; 2014 Aug; 451(2):308-13. PubMed ID: 25088994
[TBL] [Abstract][Full Text] [Related]
39. Loss of MEN1 activates DNMT1 implicating DNA hypermethylation as a driver of MEN1 tumorigenesis.
Yuan Z; Sánchez Claros C; Suzuki M; Maggi EC; Kaner JD; Kinstlinger N; Gorecka J; Quinn TJ; Geha R; Corn A; Pastoriza J; Jing Q; Adem A; Wu H; Alemu G; Du YC; Zheng D; Greally JM; Libutti SK
Oncotarget; 2016 Mar; 7(11):12633-50. PubMed ID: 26871472
[TBL] [Abstract][Full Text] [Related]
40. Increased prevalence of impaired fasting glucose in MEN1 gene mutation carriers.
van Wijk JP; Dreijerink KM; Pieterman CR; Lips CJ; Zelissen PM; Valk GD
Clin Endocrinol (Oxf); 2012 Jan; 76(1):67-71. PubMed ID: 21726266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
